Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Anti-Cancer Agents in Medicinal Chemistry
|
November 3, 2011
The stem cell niche as a pharmaceutical target for prevention of skeletal metastases
John M Chirgwin
Breast Cancer Research : BCR
|
March 11, 2015
Role of bone-anabolic agents in the treatment of breast cancer bone metastases
Attaya Suvannasankha, John M Chirgwin
Seminars in Oncology
|
October 23, 2003
Role of bisphosphonates in prostate cancer bone metastases
Theresa A Guise, John M Chirgwin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2006
Does prostate-specific antigen contribute to bone metastases?
John M Chirgwin, Theresa A Guise
Journal of Cellular Biochemistry
|
October 2, 2007
Skeletal metastases: decreasing tumor burden by targeting the bone microenvironment
John M Chirgwin, Theresa A Guise
Clinical Orthopaedics and Related Research
|
November 6, 2003
Transforming growth factor-beta in osteolytic breast cancer bone metastases
Theresa A Guise, John M Chirgwin
Proceedings of the National Academy of Sciences of the United States of America
|
June 22, 2007
Breaking new ground to build bone
Lauren A Kingsley, John M Chirgwin, Theresa A Guise
Methods in Molecular Biology (Clifton, N.J.)
|
May 9, 2008
Assessing new bone formation in neonatal calvarial organ cultures
Khalid S Mohammad, John M Chirgwin, Theresa A Guise
Current Opinion in Rheumatology
|
June 10, 2006
New insights into the role of T cells in the vicious cycle of bone metastases
Pierrick G J Fournier, John M Chirgwin, Theresa A Guise
Cancer Letters
|
April 18, 2006
The human Cyr61 gene is a transcriptional target of transforming growth factor beta in cancer cells
Laurent Bartholin, Lisa L Wessner, John M Chirgwin, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Anti-Cancer Agents in Medicinal Chemistry
|
November 3, 2011
The stem cell niche as a pharmaceutical target for prevention of skeletal metastases
John M Chirgwin
Breast Cancer Research : BCR
|
March 11, 2015
Role of bone-anabolic agents in the treatment of breast cancer bone metastases
Attaya Suvannasankha, John M Chirgwin
Seminars in Oncology
|
October 23, 2003
Role of bisphosphonates in prostate cancer bone metastases
Theresa A Guise, John M Chirgwin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2006
Does prostate-specific antigen contribute to bone metastases?
John M Chirgwin, Theresa A Guise
Journal of Cellular Biochemistry
|
October 2, 2007
Skeletal metastases: decreasing tumor burden by targeting the bone microenvironment
John M Chirgwin, Theresa A Guise
Clinical Orthopaedics and Related Research
|
November 6, 2003
Transforming growth factor-beta in osteolytic breast cancer bone metastases
Theresa A Guise, John M Chirgwin
Proceedings of the National Academy of Sciences of the United States of America
|
June 22, 2007
Breaking new ground to build bone
Lauren A Kingsley, John M Chirgwin, Theresa A Guise
Methods in Molecular Biology (Clifton, N.J.)
|
May 9, 2008
Assessing new bone formation in neonatal calvarial organ cultures
Khalid S Mohammad, John M Chirgwin, Theresa A Guise
Current Opinion in Rheumatology
|
June 10, 2006
New insights into the role of T cells in the vicious cycle of bone metastases
Pierrick G J Fournier, John M Chirgwin, Theresa A Guise
Cancer Letters
|
April 18, 2006
The human Cyr61 gene is a transcriptional target of transforming growth factor beta in cancer cells
Laurent Bartholin, Lisa L Wessner, John M Chirgwin, et al.
Page
of 4